CADL Candel Therapeutics

Watchlist

6.430
+0.380+6.28%

Close Apr 25 16:00 ET

6.630
+0.200+3.11%

Post 18:36 ET

188.70MMarket Cap-4908P/E (TTM)

About Candel Therapeutics Company

Candel Therapeutics, Inc. is a late clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Company Profile

SymbolCADL

Company NameCandel Therapeutics

Listing DateJul 27, 2021

Issue Price8.00

Founded2002

CEODr. Paul Peter Tak, M.D.,PhD

MarketNASDAQ

Employees42

Securities TypeOrdinary Shares

Fiscal Year Ends12-31

Address117 Kendrick Street,Suite 450

CityNeedham

ProvinceMassachusetts

CountryUnited States of America

Zip Code02494

Phone1-617-916-5445

Websitehttp://www.candeltx.com

Company Executives

Name
Position
Salary

Dr. Paul Peter Tak, M.D.,PhD
President, Chief Executive Officer and Director
1.84M

Charles Schoch
Interim Chief Financial Officer and Principal Accounting Officer
--

Seshu Tyagarajan, PhD,R.A.C.
Chief Technical and Development Officer
916.02K

Dr. William Garrett Nichols, M.A.,M.D.
Chief Medical Officer
--

Dr. Francesca Barone, M.D.,PhD
Chief Scienctific Officer
908.30K

Paul B. Manning
Chairman of the Board
106.24K

Dr. Estuardo Aguilar-Cordova, M.D.,PhD
Director
49.32K

Dr. Nicoletta Loggia, PhD,R.Ph.
Independent Director
--

Renee M. Gaeta
Independent Director
49.73K

Joseph C. Papa
Independent Director
50.98K

Christopher Martell
Independent Director
71.24K

Dr. Gary J. Nabel, M.D.,PhD
Independent Director
47.98K

Dr. Edward J. Benz, Jr,M.D.
Independent Director
57.24K

Dr. Diem Nguyen, M.B.A.,PhD
Independent Director
53.62K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall